Skip to main content
Premium Trial:

Request an Annual Quote

Senate Approves Sebelius for HHS Post

NEW YORK (GenomeWeb News) – The US Senate yesterday confirmed Kansas Governor Kathleen Sebelius to be Secretary of the Department of Health and Human Services by a vote of 65 to 31 with three abstentions.

Her appointment had been slowed by concern among some Republican senators primarily about differences with her positions on abortion.

Before serving as governor of Kansas, Sebelius between 1995 and 2003 was the state's insurance commissioner.

In a debate on the senate floor yesterday, Senator Tom Coburn (R – Okla.) said that the abortion concern was the only reason he would not support her nomination for the position.

Sen. Robert Bennett (R – Utah) yesterday added to that his qualms with the nominee, saying that he would vote against Sebelius because he believed she had been "less than forthcoming with her list of political donors," and because she "backs a government-run healthcare system."

In the vote, Sebelius won over nine Republican Senators, including the two from her state, and she received full support from the Democrats who voted.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.